TAVI: Medtronic lands European win for next-gen Engager heart valve

February 28, 2013 by Arezu Sarvestani

Medtronic lands CE Mark approval in the European Union for its new Engager transcatheter aortic valve implantation system.

Medtronic logo

Medical device giant Medtronic (NYSE:MDT) won European regulatory approval for its Engager transcatheter aortic valve implantation system, the company announced today.

The CE Mark indication includes approval for transapical delivery of the valve in treatment of patients with aortic stenosis who are too sick to undergo traditional surgery.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp